secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001477932-24-005537
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab reduces stockholder meeting quorum to one-third
-----------------------------------------------------------------

- Board adopted amended bylaws on September 4, 2024, effective immediately.
- Quorum for stockholder meetings lowered from majority to one-third of outstanding voting shares.
- Amendment aligns with other governance provisions; no other bylaw changes disclosed.
- Amended and Restated Bylaws filed as Exhibit 3.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/0001477932-24-005537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-005537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer